SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NTII - Miscellaneous
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
1296 22 0 NTII
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
11962005 - Anti-allodynic interactions between NMDA receptor channel blockers and moJohn McCarthy-8/20/2005
11952005 - Memantine reduces hematoma expansion in experimental intracerebral hemorrJohn McCarthy-8/20/2005
11942005 - Memantine in Treating Heroin-Dependent Individuals - 1 Effectiveness of John McCarthy-8/17/2005
11932005 - Memantine pharmacology elucidated in mice Pain & Central Nervous SysJohn McCarthy-8/17/2005
11922005 - Memantine for Migraine Treatments Typically Used in Neurologic Settings:John McCarthy-8/17/2005
11912005 - Scientists link vascular gene to Alzheimer's disease Scientists at John McCarthy-8/15/2005
11902005 Cognitive evaluation of disease-modifying efficacy of Galantamine and MemanJohn McCarthy-8/14/2005
1189Nasal spray clears Alzheimer’s brain plaques 20:00 11 August 2005 NewScientist.Pogeu Mahone-8/12/2005
11882005 - Delusions and hallucinations in dementia with Lewy bodies: Worsening withJohn McCarthy-8/10/2005
11872000 - Memantine and IL-1 reductino [Akatinol memantin in Alzheimer's diseaJohn McCarthy-8/1/2005
11862005 - Anti-inflammatory Function Of Alzheimer's Disease Drugs Revealed ThJohn McCarthy-8/1/2005
11852005 - Injection for diabetic nerve pain Patients are to test a trial treatmenJohn McCarthy-8/1/2005
1184Hi Maven - <<<<<< any thoughts on the recent FRX developmentsJohn McCarthy-7/14/2005
1183John--any thoughts on the recent FRX developments?Maven1-7/14/2005
11822005 - Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hipJohn McCarthy-7/13/2005
11812005 - Neuropathic Pain Market to Reach $3.5 Billion by 2014, Despite Generic NeJohn McCarthy-7/11/2005
1180Hi Maven <<<<<<< What is connection to NTII? <<<John McCarthy-6/30/2005
1179What is connection to NTII?Maven1-6/30/2005
11782005 - Neurochem announces FDA agrees to file and review NDA for Fibrillex(TM) John McCarthy-6/30/2005
11772005 - Combination of an NMDA receptor antagonist and a selective serotonin reupJohn McCarthy-6/13/2005
11762005 - Gamma Secretase Modulator Program Announced for Alzheimer's disease John McCarthy-6/5/2005
11752005 - Anxious wait over drugs review June 1, 2005 16:58 ALZHEIMERS patients John McCarthy-6/2/2005
11742005 - Current FRX Memantine Trials .... Study ID: MEM-MD-03 Title: A Long-TerJohn McCarthy-6/1/2005
11732005 - On the paradox of ion channel blockade and its benefits in the treatment John McCarthy-6/1/2005
11722005 - New Memantine Trial Efficacy and Safety of Memantine Hydrochloride, a lJohn McCarthy-6/1/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News